While some studies have suggested a tumor suppressor function of SIRT6 in liver and intestinal cancers [18, 21, 22], others have shown that it has oncogenic properties in prostate cancer and non-melanoma skin cancer [23-25]. Here, SIRT6 is linked to intestinal cancer.